“二孩”生育政策后再生育的临床思考
Clinical concern of the second pregnancy under the two-child policy

DOI: 10.6040/j.issn.1671-7554.0.2016.1479

Keywords: 辅助生殖技术,高龄生育,二胎政策,
Two-child policy,Fertility in Advanced Age,Assisted reproductive technology

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Ganie MA, Marwaha RK, Dhingra A, et al. Observation of phenotypic variation among Indian women with polycystic ovary syndrome(PCOS)from Delhi and Srinagar[J]. Gynecol Endocrinol, 2016, 32(7): 566-570.
[2]	Kupka MS, Ferraretti AP, de Mouzon J, et al. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE[J]. Hum Reprod, 2014, 29(10): 2099-2113.
[3]	Bonne S, Sauleau E, Sananes N, et al. Influence of medically assisted reproduction techniques on crown-rump length and biochemical markers of trisomy 21 in the first trimester of pregnancy[J]. Fertil Steril, 2016, 105(2): 410-416.
[4]	Cui L, Qin Y, Gao X, et al. Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause[J]. Fertil Steril, 2016, 105(2): 481-485.e1.
[5]	Navot D, Bergh PA, Williams MA, et al. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility[J]. Lancet, 1991, 337(8754): 1375-1377.
[6]	Cui Y, Shi Y, Cui L, et al. Age-specific serum antimullerian hormone levels in women with and without polycystic ovary syndrome[J]. Fertil Steril, 2014,102(1): 230-236.e2.
[7]	Wennberg AL, Opdahl S, Bergh C, et al. Effect of maternal age on maternal and neonatal outcomes after assisted reproductive technology[J]. Fertil Steril, 2016, 106(5): 1142-1149. e14.
[8]	Rosato E, Perrone G, Capri O, et al. Hypertension and early menopause after the use of assisted reproductive technologies in women aged 43 years or older: Long-term follow-up study[J]. J Obstet Gynaecol Res, 2016, Epub 2016/10/09. doi: 10.1111/jog.13141.
[9]	Fitzpatrick KE, Tuffnell D, Kurinczuk JJ, et al. Pregnancy at very advanced maternal age: a UK population-based cohort study[J]. BJOG, 2016, 1. doi: 10.1111/1471-0528.14269.[Epub ahead of print]
[10]	Youssef MA, van Wely M, Al-Inany H, et al. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial[J]. Hum Reprod, 2016, Epub 2016/11/12. doi: 10.1093/humrep/dew282.
[11]	Ferraretti AP, Goossens V, Kupka M, et al. Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE[J]. Hum Reprod, 2013, 28(9): 2318-2331.
[12]	Wu B, Shi J, Zhao W, et al. Understanding reproducibility of human IVF traits to predict next IVF cycle outcome[J]. J Assist Reprod Genet, 2014, 31(10): 1323-1330.
[13]	Yang Y, Sun X, Cui L, et al. Younger poor ovarian response women achieved better pregnancy results in the first three IVF cycles[J]. Reprod Biomed Online, 2016, 32(5): 532-537.
[14]	Ferraretti AP, Goossens V, de Mouzon J, et al. Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE[J]. Hum Reprod, 2012, 27(9): 2571-2584.
[15]	Matorras R, Matorras F, Mendoza R, et al. The implantation of every embryo facilitates the chances of the remaining embryos to implant in an IVF programme: a mathematical model to predict pregnancy and multiple pregnancy rates[J]. Humreprod, 2005, 20(10): 2923-2931.
[16]	Pirjani R, Seifmanesh F, Tehranian A, et al. Placental implantation and migration following a previous caesarean section scar[J]. Aust N Z J Obstet Gynaecol, 2016, Epub 2016/11/20. doi: 10.1111/ajo.12555.
[17]	金敏丽. 140例剖宫产后疤痕子宫再次妊娠分娩方式的临床分析[J]. 中华全科医学, 2014, 12(10): 1614-1616. JIN Minli. Clinical analysis of delivery method in 140 cases of cesarean scar pregnancy[J]. Chinese Journal of General Practice, 2014, 12(10): 1614-1616.
[18]	Tietze C. Reproductive span and rate of conception among Hutterite women[J]. Fertil Steril, 1957, 8(1): 89-97.
[19]	Lumbiganon P, Laopaiboon M, Gtllmezoglu AM, et al. Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-2008[J]. Laneet, 2010, 375(9713): 490-499.
[20]	Yu L, Su CH, Wang XY, et al. Multi-centric clinical study of trial of labor after cesarean section[J]. Zhonghua Fu Chan Ke Za Zhi, 2016, 51(8): 581-585.
[21]	Landon MB, Hauth JC, Leveno KJ, et al. Matemal and perinatal outcomes associated with a trial of labor after prior cesarean delivery[J]. N Eng J Med, 2004, 351(25): 2581-2589.
[22]	张进先. 瘢痕子宫再次妊娠分娩方式的选择及经阴道分娩安全性的临床分析[J]. 中国当代医药, 2015, 13(22): 113-115. ZHANG Jinxian. Clinical analysis on the selection of delivery mode for secondary pregnancy of cicatricial uterus and the safety of vaginal delivery[J]. China Modern Medicine, 2015, 13(22): 113-115.
[23]	Thomopoulos C, Tsioufis C, Michalopoulou H, et al. Assisted reproductive technology and pregnancy-related hypertensive complications: a systematic review[J]. J Human Hypertens, 2013, 27(3): 148-157.
[24]	Tatsumi T, Jwa SC, Kuwahara A, et al. No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology[J]. Hum Reprod, 2016. Epub 2016/11/09. doi: 10.1093/humrep/dew280.
[25]	Davies MJ, Rumbold AR, Marino JL, et al. Maternal factors and the risk of birth defects after IVF and ICSI: a whole of population cohort study[J]. BJOG, 2016. Epub 2016/10/18. doi: 10.1111/1471-0528.14365.

Full-Text